Stock Analiz

Elicio Therapeutics, Inc. (ELTX) stock forecast and price target

Price $1.50 · data as of November 13, 2026

12-month price target

Average target$13.00
Upside / downside+766.7%
Analysts3
ConsensusBuy
Low $8.00Average $13.00High $21.00

Gold marker: average target · white marker: today’s price ($1.50)

Analyst ratings

Strong buy 0Buy 2Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.68+34.8%$0
Next fiscal year
ends December 31, 2027
$-1.42+15.9%$0
Next quarter
ends December 31, 2026
$-0.35+29.2%$0
Quarter after
ends March 31, 2027
$-0.37+43.6%$0

Consensus of the analysts covering Elicio Therapeutics, updated daily.

Frequently asked questions

What is the Elicio Therapeutics stock price target?

The average 12-month target from 3 analysts is $13.00, 766.7% above the current price of $1.50 Targets range from $8.00 to $21.00.

Is Elicio Therapeutics a buy according to analysts?

The consensus rating is “Buy” (2 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Elicio Therapeutics expected to earn?

Analysts expect EPS of $-1.68 for the fiscal year ending December 31, 2026 and $-1.42 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.